Herein, we comprehensively inspect the interrelation between CIA‐II expression and prognosis, clinical traits, specific functions, tumor immunity, gene mutations, and sensitivity to chemotherapeutics in LGG patients from TCGA and CGGA cohorts. The gene discussed is ASF1B; the disease is neoplasm.